Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Clinical Neuropharmacology|November 1, 2002
Olanzapine for Huntington's disease: an open label studyRaphael M Bonelli, Franz A Mahnert, Gerald NiederwieserHuman Psychopharmacology|April 3, 2003
Zotepine in Huntington's diseaseRaphael M Bonelli, Gerald Niederwieser, Theresa Lahousen, et al.Acta Medica Austriaca|September 14, 2004
Transient hypoglycemic abducens palsySusanna Anhaus, Raphael M Bonelli, Gerald Niederwieser, et al.Clinical Neuropharmacology|February 20, 2002
Pramipexole ameliorates neurologic and psychiatric symptoms in a Westphal variant of Huntington's diseaseRaphael M Bonelli, Gerald Niederwieser, Josef Diez, et al.Neurobiology of Disease|December 4, 2002
Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer's diseaseRaphael M Bonelli, Andreas Aschoff, Gerald Niederwieser, et al.Journal of Psychopharmacology (Oxford, England)|February 12, 2004
Ziprasidone in Huntington's disease: the first case reportsRaphael M Bonelli, Brigitte M Mayr, Gerald Niederwieser, et al.International Clinical Psychopharmacology|April 7, 2005
The influence of psychotropic drugs on cerebral cell death: female neurovulnerability to antipsychoticsRaphael M Bonelli, Peter Hofmann, Andreas Aschoff, et al.Journal of Neurology|June 11, 2003
Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosisGerald Niederwieser, Wolfgang Buchinger, Raphael M Bonelli, et al.Expert Opinion on Pharmacotherapy|April 23, 2004
A review of the treatment options for Huntington's diseaseRaphael M Bonelli, Peter HofmannExpert Opinion on Pharmacotherapy|January 30, 2007
A systematic review of the treatment studies in Huntington's disease since 1990Raphael M Bonelli, Peter HofmannPageof 4